MedTrace Logo

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

NCT00298194 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2009-01-14

No results posted yet for this study

Summary

To assess in subjects with and without functional dyspepsia the effects of Z-338 on:

1. Type and severity of symptoms a standardized nutrient challenge
2. The gastric nutrient distribution and gastric emptying of a standardized nutrient challenge
3. The association of the above with the manifestations of symptoms and symptom pattern

Conditions

  • Dyspepsia

Interventions

DRUG

Z-338

Sponsors & Collaborators

  • Zeria Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Gerald Holtmann, Professor · Royal Adelaide Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-07-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00298194 on ClinicalTrials.gov